Skip to main content
Top

Clinical & Experimental Metastasis

Issue 1/2015

Content (9 Articles)

Research Paper

Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases

L. Bollen, C. Wibmer, M. Wang, Y. M. van der Linden, A. Leithner, C. E. Bünger, A. B. Jensen, M. Fiocco, G. Bratschitsch, W. Pondaag, J. V. M. G. Bovée, P. D. S. Dijkstra

Research Paper

Bone metastases in gastrointestinal cancer

Fabienne Portales, Simon Thézenas, Emmanuelle Samalin, Eric Assenat, Thibault Mazard, Marc Ychou

Research Paper

STC1 expression is associated with tumor growth and metastasis in breast cancer

Andy C-M Chang, Judy Doherty, Lily I. Huschtscha, Richard Redvers, Christina Restall, Roger R. Reddel, Robin L. Anderson

Research Paper

T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2

Roberta Nicoletti, Salvatore Lopez, Stefania Bellone, Emiliano Cocco, Carlton L. Schwab, Jonathan D. Black, Floriana Centritto, Liancheng Zhu, Elena Bonazzoli, Natalia Buza, Pei Hui, Delia Mezzanzanica, Silvana Canevari, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Santin

Research Paper

A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway

Yuan Wang, Lin Yuan, Xiang-Min Yang, Ding Wei, Bin Wang, Xiu-Xuan Sun, Fei Feng, Gang Nan, Ye Wang, Zhi-Nan Chen, Huijie Bian

Research Paper

Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma

Sabrina Daniela da Silva, Grégoire B. Morand, Faisal A. Alobaid, Michael P. Hier, Alex M. Mlynarek, Moulay A. Alaoui-Jamali, Luiz Paulo Kowalski

Research Paper

Host Cxcr2-dependent regulation of mammary tumor growth and metastasis

Bhawna Sharma, Kalyan C. Nannuru, Michelle L. Varney, Rakesh K. Singh

Research Paper

Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells

Ting-Chung Wang, Sheng-jie Luo, Chun-Liang Lin, Pey-Jium Chang, Miao-Fen Chen

RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma

Wei Guo, Cong Wang, Yanli Guo, Supeng Shen, Xin Guo, Gang Kuang, Zhiming Dong

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine